Common Gynecologic Infections

Primary Care - Clinics in Office Practice

Volumn 36, Issue 1, 2009, Pages 33-51

  Biggs, Wendy S ^a,b   Williams, Rachel M ^c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Midland Family Medicine Residency Program   (United States)

^c Department of Internal Medicine   (United States)

Author keywords

Bacterial vaginosis; Candidiasis; Chlamydia; Gonorrhea; Herpes simplex virus; Sexually transmitted infection; Trichomonas; Vaginitis

Indexed keywords

ACICLOVIR; AMOXICILLIN; AZITHROMYCIN; BENZATHINE PENICILLIN; BORIC ACID; BUTOCONAZOLE; CEFIXIME; CEFTIZOXIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; CLOTRIMAZOLE; DOXYCYCLINE; ERYTHROMYCIN; ERYTHROMYCIN ETHYLSUCCINATE; FAMCICLOVIR; FLUCONAZOLE; GYNAZOLE 1; GYNE LOTRIMIN 3; GYNE LOTRIMIN 7; LEVOFLOXACIN; METRONIDAZOLE; MICONAZOLE; MONISTAT 7; MYCELEX 3; NYSTATIN; OFLOXACIN; PENICILLIN G; SPECTINOMYCIN; TERAZOL 3; TERCONAZOLE; TETRACYCLINE; TINIDAZOLE; TIOCONAZOLE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VAGISTAT 7; VALACICLOVIR;

ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; CHLAMYDIA; CHLAMYDIASIS; CLINICAL EXAMINATION; DIFFERENTIAL DIAGNOSIS; DRUG COST; DRUG FORMULATION; DRUG RELEASE; ENDEMIC DISEASE; FLUSHING; GASTROINTESTINAL SYMPTOM; GENITAL HERPES; GONORRHEA; GYNECOLOGIC INFECTION; HEADACHE; HEALTH CARE PERSONNEL; HEART PALPITATION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTENSION; INCIDENCE; LYMPHOGRANULOMA VENEREUM; NAUSEA; NUCLEIC ACID AMPLIFICATION; PAPANICOLAOU TEST; PATIENT COMPLIANCE; PELVIC INFLAMMATORY DISEASE; PH; PREGNANCY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RECURRENT INFECTION; REVIEW; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SIDE EFFECT; SINGLE DRUG DOSE; SYMPTOM; SYPHILIS; THIRST; THORAX PAIN; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; ULCUS MOLLE; UTERINE CERVICITIS; VAGINA CANDIDIASIS; VAGINA FLORA; VAGINITIS; VERTIGO; VOMITING; VULVITIS;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ANTIVIRAL AGENTS; CANDIDIASIS, VULVOVAGINAL; CHLAMYDIA INFECTIONS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENITAL DISEASES, FEMALE; GONORRHEA; HERPES GENITALIS; HUMANS; PELVIC INFLAMMATORY DISEASE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SYPHILIS; TRICHOMONAS VAGINITIS; VAGINOSIS, BACTERIAL;

EID: 60249090091     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2008.10.002     Document Type: Review

References (47)

1. Armstrong G., Schillinger J., Markowitz L., et al. Incidence of herpes simplex virus type 2 infection in the United States. Am J Epidemiol 153 (2001) 912-920
2. Fleming D.T., McQuillan G.M., Johnson R.E., et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 337 16 (1997) 1105-1111
3. Xu F., Sternberg M.R., Kottiri B.J., et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. J Am Med Assoc 296 8 (2006) 964-973
4. Ashley R.L., and Wald A. Genital herpes: review of the epidemic and potential use of type-specific serology. Clin Microbiol Rev 12 1 (1999) 1-8
5. Corey L., Wald A., Patel R., et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 350 1 (2004) 11-19
6. Sacks S.L. Famiciclovir suppression of asymptomatic and symptomatic recurrent anogenital herpes simplex virus shedding in women: a randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single center trial. J Infect Dis 189 8 (2004) 1341-1347
7. ACOG practice bulletin. Management of herpes in pregnancy. Number 8, October 1999. Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet 68 2 (2000) 165-173
8. U.S. Preventive Services Task Force (USPSTF). Screening for genital herpes: recommendation statement (2005), Agency for Healthcare Research and Quality (AHRQ), Rockville (MD) p. 11
9. Centers for Disease Control and Prevention. Sexually transmitted disease treatment guidelines, 2006. MMWR Recomm Rep 55 RR-11 (2006) 1-95
10. Centers for Disease Control and Prevention. 2006 Syphilis surveillance report supplement. Available at: www.cdc.gov/std/Syphilis2006/Syphilis2006Complete.pdf. Accessed August 20, 2008.
11. Centers for Disease Control and Prevention website. Available at:. www.cdc.gov/std/Trends2000/chancroid.htm Accessed August 15, 2008
12. Mabey D., and Peeling R.W. Lymphogranuloma venereum. Sex Transm Infect 78 (2002) 90-92
13. Van Vranken M. Prevention and treatment of sexually transmitted diseases: an update. Am Fam Physician 76 12 (2007) 1827-1832
14. Anderson M.R., Klink K., and Cohrssen A. Evaluation of vaginal complaints. JAMA 291 11 (2004) 1368-1378
15. Eckert E.O., Hawes S.E., Stevens C.E., et al. Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm. Obstet Gynecol 07 (1998) 757-765
16. Chandeying V., Skov S., Kempanmanus M., et al. Evaluation of two clinical protocols for the management of women with vaginal discharge in southern Thailand. Sex Transm Infect 74 (1998) 194-201
17. Pharmacy Times. Available at: http://www.pharmacytimes.com/issues/articles/2006-06_3567.asp. Accessed July 4, 2008.
18. ACOG. ACOG practice bulletin. Vaginitis. Obstet Gynecol 107 5 (2006) 1195-1206
19. Sobel J.D., Kapernick P.S., Zervos M., et al. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. Am J Obstet Gynecol 185 (2001) 363-369
20. Sobel J.D., Wiesenfeld H.C., Martens M., et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med 351 (2004) 876-883
21. Sobel J.S., Chaim W., Nagapan V., et al. Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine. Am J Obstet Gynecol 189 (2003) 1297-1300
22. O'Dowd T.C., and West R.R. Clinical prediction of Gardnerella vaginalis in general practice. J R Coll Gen Pract 37 (1987) 59-61
23. Landers D., Wiesenfeld H.C., Heine R.P., et al. Predictive value of the clinical diagnosis of lower genital tract infection in women. Am J Obstet Gynecol 190 (2004) 1004-1010
24. Bradshaw C.S., Morton A.N., Hocking J., et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 193 (2006) 1478-1486
25. McDonald HM, Brocklehurst P, Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2007, (1). Art No.: CD000262. 10.1002/14651858.CD000262.pub3.
26. Carey J.C., Klebanoff M.A., Hauth J.C., et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National institute of child health and human development network of maternal-fetal medicine units. N Engl J Med 342 (2000) 534-540
27. Ness R.B., Hillier S.L., Kip K.E., et al. Bacterial vaginosis and the risk of pelvic inflammatory disease. Obstet Gynecol 104 4 (2004) 761-769
28. Schwebke J.R., and Desmond R. A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases. Am J Obstet Gynecol 196 6 (2007) 517 e1-6
29. Hutchinson K.B., Kip K.E., and Ness R.B. Condom use and its association with bacterial vaginosis and bacterial vaginosis-associated vaginal microflora. Epidemiology 18 6 (2007) 702-708
30. Sutton M., Sternberg M., Koumans E.H., et al. The prevalence of Trichomonas vaginalis infection among reproductive age women in the United States, 2001-2004. Clin Infect Dis 45 (2007) 1319-1326
31. Wiese W., Patel S.T., Patel S.C., et al. A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am J Med 108 (2000) 301-308
32. Carr P.L., Rothberg M.B., Friedman R.H., et al. "Shotgun" versus sequential testing: cost-effectiveness of diagnostic strategies for vaginitis. J Gen Intern Med 20 (2005) 793-799
33. Heppert J.S., Batteiger B.E., Braslins P., et al. Use of an immunochromatographic assay for rapid detection of trichomonas vaginalis in vaginal specimens. J Clin Microbiol 43 (2005) 684-687
34. Caro-Paton T., Carvajal A., Martin de Diego I., et al. Is metronidazole teratogenic? A meta-analysis. Br J Clin Pharmacol 44 2 (1997) 179-182
35. Klebanoff M.A., Carey J.C., Hauth J.C., et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 345 7 (2001) 487-493
36. Shennan A., Crawshaw S., Briley A., et al. A randomized controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET study. BJOG 113 1 (2006) 65-74
37. Van der Pol B., Kwok C., Pierre-Louis B., et al. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis 197 4 (2008) 548-554
38. Abbott J. Clinical and microscopic diagnosis of vaginal yeast infection: a prospective analysis. Ann Emerg Med 25 (1995) 587-591
39. Schaaf M.V., Perez-Stable E.J., and Borchardt K. The limited value of symptoms and signs in the diagnosis of vaginal infections. Arch Intern Med 150 (1990) 1929-1933
40. Stansfield V. Diagnosis and management of anorectal gonorrhea in women. Br J Vener Dis 56 (1980) 319-321
41. Center for Disease Control. Trends in reportable sexually transmitted diseases in the United States, 2006. CDC Available at: www.cdc.gov/std/stats/trends2006.htm Accessed August 4, 2008.
42. Meyers D., Gregory K., Nelson H., et al. USPSTF recommendations for STI screening. Am Fam Physician 77 6 (2008) 819-824
43. Centers for Disease Control. Update to CDC's sexually transmitted disease treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Recomm Rep 56 14 (2007) 332-336. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5614a3.htm Accessed August 4, 2008
44. Schink J.C., and Keith L.G. Problems in the culture diagnosis of gonorrhea. J Reprod Med 30 (1985) 244-249
45. Jensen J.S. Mycoplasma genitalium: the aetiologial agent of urethritis and other sexually transmitted diseases. J Eur Acad Dermatol Venereol 18 1 (2004) 1-11
46. Angarius C., Lore B., and Jensen J.S. Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sex Transm Infect 81 6 (2005) 458-462
47. He Q., Martinez-Sobrido L., Edo F.O., et al. Live-attenuated influenza viruses as delivery vectors for chlamydia vaccines. Immunology 122 2 (2007) 28-37 [Epub 2007 Apr 23]